Evidence map›Paper›PMID 37386798›Full record

ArticleNeuropathology and applied neurobiology2023

Psychotic symptoms in frontotemporal dementia with TDP-43 tend to be associated with type B pathology.

Veronica Hirsch-Reinshagen, Christa Hercher, Fidel Vila-Rodriguez, Manuela Neumann, Rosa Rademakers, William G Honer, Ging-Yuek R Hsiung, Ian R Mackenzie

Open access · bronzeAbstract read
In one paragraph

Article in Neuropathology and applied neurobiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Veronica Hirsch-ReinshagenDepartment of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada.
Christa HercherDouglas Mental Health University Institute, McGill University, Montreal, Canada.
Fidel Vila-RodriguezDepartment of Psychiatry, University of British Columbia, Vancouver, Canada.
Manuela NeumannMolecular Neuropathology of Neurodegenerative Diseases, German Center for Neurodegenerative Diseases, Göttingen, Germany.ORCID 0000-0002-6232-4057
Rosa RademakersApplied and Translational Neurogenomics, VIB Center for Molecular Neurology, Edegem, Belgium.
William G HonerDepartment of Psychiatry, University of British Columbia, Vancouver, Canada.
Ging-Yuek R HsiungDivision of Neurology, University of British Columbia, Vancouver, Canada.
Ian R MackenzieDepartment of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada.
University of British Columbia · CAGerman Center for Neurodegenerative Diseases · DEUniversity of Antwerp · BE

Funding

Technology and Remote Assessment CoreU19AG063911 · NIA · MAYO CLINIC ROCHESTER · PI ADAM L. BOXER, Bradley F Boeve · 2019 to 2026
$120.9M
TDP-43 Loss-of-Function: Biology to BiomarkersP01AG019724 · NIA · UNIVERSITY OF PENNSYLVANIA · PI Jennifer Merrilees · 2002 to 2026
$67.2M
NIA NIH HHS P01 AG019724NIA NIH HHS U19 AG063911
6 · The paper itself

Abstract

aimsPsychotic symptoms are increasingly recognized as a distinguishing clinical feature in patients with dementia due to frontotemporal lobar degeneration with TDP-43 pathology (FTLD-TDP). Within this group, carriers of the C9orf72 repeat expansion are particularly prone to develop delusions and hallucinations.

methodsThe present retrospective study sought to provide novel details about the relationship between FTLD-TDP pathology and the presence of psychotic symptoms during life.

resultsWe found that FTLD-TDP subtype B was more frequent in patients with psychotic symptoms than in those without. This relationship was present even when corrected for the presence of C9orf72 mutation, suggesting that pathophysiological processes leading to the development of subtype B pathology may increase the risk of psychotic symptoms. Within the group of FTLD-TDP cases with subtype B pathology, psychotic symptoms tended to be associated with a greater burden of TDP-43 pathology in the white matter and a lower burden in lower motor neurons. When present, pathological involvement of motor neurons was more likely to be asymptomatic in patients with psychosis.

conclusionsThis work suggests that psychotic symptoms in patients with FTLD-TDP tend to be associated with subtype B pathology. This relationship is not completely explained by the effects of the C9orf72 mutation and raises the possibility of a direct link between psychotic symptoms and this particular pattern of TDP-43 pathology.

Indexed as

Frontotemporal DementiaFrontotemporal Lobar DegenerationPsychotic DisordersC9orf72 ProteinDNA-Binding ProteinsHumansRetrospective StudiesC9orf72 ProteinDNA-Binding ProteinsTARDBP protein, humanALSfrontotemporal dementiaFTLD-TDPhistologypsychosis

Identifiers

PMID37386798
PMCPMC10527970
OpenAlexW4382631151

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.